Open access
Aug 2026
Structure-Based Identification of HFS764 as an Inhibitor of the HIF-1α–p300 Interface in Hypoxic Renal Cell Carcinoma
HFS764 disrupts the HIF-1α–p300 interface and suppresses hypoxia-driven signaling in ccRCC, supporting the use of transcriptional complex inhibition as a promising therapeutic strategy.
Mesfer Al Shahrani
· Discover medicine · 0 citations